Baldwin AS in 2010 using Her2+/ER- breast cancer cells, showed that HER2 activates NF-kappa B via IKKα and hypothesized that NIK might be activating IKKα since NIK has been associated to the ErbB2 family member EGFR37. The gene discussed is MAP3K14; the disease is breast carcinoma.